Novartis Investigative Site

Erbach im Odenwald 64711

0 studies enrolling now · 2 studies all time

What they study most

Relapsing Forms of Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed